Skip to content
Alivexis, Inc.
Unveiling the Future of Medicine
Menu
Home
Science
Pipeline
About Us
News
Public Notice
Contact Us
日本語
News
News
Modulus Discovery, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
- 13 December, 2022
Modulus Discovery Announces Research Collaboration with Fujitsu on the Implementation and Optimization of ModBind™, A Novel Computational Technology for Drug Discovery
- 08 August, 2022
Modulus Discovery Closes $20.4M USD Series C
- 01 March, 2022
40th Annual J.P. Morgan Healthcare Conference － Modulus Discovery Presentation
- 14 January, 2022
Nissan Chemical and Modulus Discovery Jointly Announce Signing of Strategic Drug Discovery Collaboration Agreement
- 21 April, 2021
39th Annual J.P. Morgan Healthcare Conference － Modulus Discovery Presentation
- 26 January, 2021
Modulus Discovery, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
- 14 December, 2020
Modulus Discovery Announces Signing of a Collaboration Agreement with the University Of Tokyo to Pursue Drug Discovery for COVID-19 and Related Emerging Virus Infections
- 02 October, 2020
Modulus Discovery Receives “Mizuho Innovation Award”
- 28 July, 2020
Modulus Discovery Closes $25.5M USD Series B
- 13 May, 2020
Previous
Next
Press & Media Contact
Email address protected by JavaScript.
Please enable JavaScript to contact me.
Latest Release
Alivexis to Present at ACS Spring Conference
Alivexis Announces Notice of U.S. Patent Registration for Novel Cathepsin C Inhibitor
Alivexis and OHARA Pharmaceutical Co., Ltd. to Collaborate on Selected Drug Targets
Alivexis Announces Receipt of Intention to Exercise Option Right from Astellas Pharma Inc. for Collaboration on Novel Drug Target
Notice of Selection for the Ministry of Economy, Trade and Industry’s Domestic Generative AI Development Strengthening Project “GENIAC”
